Published on
A decade after the MOMS trial, new findings show significant physical and emotional benefits in school-age children who had prenatal surgery for spina bifida.
Published on
Bronchiolitis, a lung infection that is one of the most common reasons for hospitalizations in young children, is most prevalent during the winter months and is usually treated with albuterol delivered via inhalers, despite evidence showing no benefit in most patients. A multidisciplinary team of researchers from Children’s Hospital of Philadelphia (CHOP) redesigned the hospital’s standard treatment for the infection and reduced albuterol use without compromising care.
Published on
A multi-center team of researchers led by Children’s Hospital of Philadelphia (CHOP) has discovered a genetic signature that could help distinguish an adult-onset form of diabetes sharing many type 1 diabetes (T1D) characteristics from pediatric-onset T1D.
Published on
More than 50 clinicians and researchers from the Cardiac Center at CHOP participated in the AHA Meeting, with six presentation nominated for awards.
Published on
Entercom raised $257,268 to support Child Life & Family Services at Children’s Hospital of Philadelphia during the 18th annual “98.1 WOGL Loves Our Kids Radiothon.”
Published on
Scientists at Children’s Hospital of Philadelphia have developed a new open-source algorithm that can detect with high sensitivity disease-causing structural variants in the genome.
Published on
Children’s Hospital of Philadelphia’s Office of Diversity & Inclusion (ODI) wins 2019 Excellence Award for Outstanding Diversity Program.
Published on
CHOP-led scientists uncovered key details of a basic process in biology: how a cell’s nucleus and chromosome structures reorganize after cell division. The research may offer insights into human health and disease.
Published on
Children’s Hospital of Philadelphia (CHOP) is proud to announce a partnership with The Enterprise Center, in conjunction with Philadelphia Housing Development Corporation (PHDC), to build the number of licensed contractors in Philadelphia and expand CHOP’s Community Asthma Prevention Program Plus Home Repairs (CAPP+) initiative.
Published on
The US Food and Drug Administration has approved two new breakthrough therapies for patients with sickle cell disease (SCD), and we believe both may enhance the treatment of our patients here at CHOP.